Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
Clinical trial NCT04155749 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04155749
- Sponsor
- Kite, A Gilead Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2024-10-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.